Education
About Us
Working with TipRanks
Follow Us
AbbVie (DE:4AB)
XETRA:4AB
Total Valuation
AbbVie has a market cap or net worth of €279.78B. The enterprise value is €376.68B.
Market Cap€279.78B
Enterprise Value€376.68B
Share Statistics
AbbVie has 1.77B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.77B
Owned by Insiders0.07%
Owned by Instutions0.79%
Financial Efficiency
AbbVie’s return on equity (ROE) is 1.29 and return on invested capital (ROIC) is 10.21%.
Return on Equity (ROE)128.66%
Return on Assets (ROA)3.17%
Return on Invested Capital (ROIC)10.21%
Return on Capital Employed (ROCE)9.48%
Revenue Per Employee€1,024,254.545
Profits Per Employee€77,781.818
Employee Count55,000
Asset Turnover0.42
Inventory Turnover4.04
Valuation Ratios
The current PE Ratio of AbbVie is 73.33. AbbVie’s PEG ratio is -6.46.
PE Ratio73.33
PS Ratio5.57
PB Ratio94.34
Price to Fair Value94.34
Price to FCF16.68
Price to Operating Cash Flow16.68
PEG Ratio-6.46
Income Statement
In the last 12 months, AbbVie had revenue of €56.33B and earned €4.28B in profits. Earnings per share was €2.41.
Revenue€56.33B
Gross Profit€41.47B
Operating Income€9.14B
Pretax Income€3.72B
Net Income€4.28B
EBITDA18.15B
Earnings Per Share (EPS)2.41
Cash Flow
In the last 12 months, operating cash flow was €18.81B and capital expenditures -€974.00M, giving a free cash flow of €17.83B billion.
Operating Cash Flow€18.81B
Free Cash Flow€17.83B
Free Cash Flow per Share€10.08
Dividends & Yields
AbbVie pays an annual dividend of €1.45, resulting in a dividend yield of 3.56%
Dividend Per Share€1.45
Dividend Yield3.56%
Payout Ratio63.00%
Free Cash Flow Yield6.00%
Earnings Yield1.36%
Stock Price Statistics
Beta0.23
52-Week Price Change1.71%
50-Day Moving Average184.43
200-Day Moving Average172.08
Relative Strength Index (RSI)29.26
Average Volume (3m)951.00
Important Dates
AbbVie upcoming earnings date is Apr 25, 2025, Before Open.
Last Earnings DateJan 31, 2025
Next Earnings DateApr 25, 2025
Ex-Dividend DateApr 15, 2025
Financial Position
AbbVie as a current ratio of 0.66, with Debt / Equity ratio of 20.19
Current Ratio0.66
Quick Ratio0.55
Debt to Market Cap0.21
Net Debt to EBITDA4.13
Interest Coverage Ratio3.25
Taxes
In the past 12 months, AbbVie has paid -€570.00M in taxes.
Income Tax-€570.00M
Effective Tax Rate-15.34%
Enterprise Valuation
AbbVie EV to EBITDA ratio is 25.17, with an EV/FCF ratio of 19.96.
EV to Sales6.66
EV to EBITDA25.17
EV to Free Cash Flow19.96
EV to Operating Cash Flow19.96
Balance Sheet
AbbVie has €5.55B in cash and marketable securities with €67.14B in debt, giving a net cash position of €61.59B billion.
Cash & Marketable Securities€5.55B
Total Debt€67.14B
Net Cash€61.59B
Net Cash Per Share€34.82
Tangible Book Value Per Share-€51.92
Margins
Gross margin is 69.99%, with operating margin of 16.22%, and net profit margin of 7.59%.
Gross Margin69.99%
Operating Margin16.22%
Pretax Margin6.60%
Net Profit Margin7.59%
EBITDA Margin26.47%
EBIT Margin11.58%
Analyst Forecast
The average price target for AbbVie is €188.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€188.92
Price Target Upside23.47%
Analyst ConsensusModerate Buy
Analyst Count16
Revenue Growth Forecast
EPS Growth Forecast